Home > Financial Ratios > NURECA

NURECA
Core EBITDA Margin

    Back to All Ratios
NURECA is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

NURECA Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Margin(%) -6.40-10.23-12.8720.5527.36

What is the latest Core EBITDA Margin ratio of NURECA ?

The latest Core EBITDA Margin ratio of NURECA is -6.40 based on Mar2025 Consolidated results.
Year Core EBITDA Margin
Mar2025-6.40
Mar2024-10.23
Mar2023-12.87
Mar202220.55
Mar202127.36

How is Core EBITDA Margin of NURECA Trending?

Years Core EBITDA Margin % Change
Mar2025 -6.4
Negative
Mar2024 -10.23
Negative
Mar2023 -12.87
Negative
Mar2022 20.55
-24.89
Mar2021 27.36 -

Other Financial Ratios of NURECA


Compare Core EBITDA Margin ratio of peers of NURECA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NURECA ₹250.6 Cr 2.9% -2% 25.3% Stock Analytics
POLY MEDICURE ₹14,882.1 Cr 4.2% 14.3% -27.6% Stock Analytics


NURECA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NURECA

2.9%

-2%

25.3%

SENSEX

2.4%

3.2%

5.8%


You may also like the below Video Courses